nctId: NCT06262789 id: 49RC23_0011 briefTitle: RAT-HEMATO : Return to Work After Malignant Hemopathy acronym: RAT-HEMATO overallStatus: NOT_YET_RECRUITING date: 2024-03-15 date: 2027-04-01 date: 2027-04-01 date: 2024-02-16 date: 2024-02-16 name: University Hospital, Angers class: OTHER_GOV briefSummary: Return to work (RTW) of patients after cancer treatment has been a topic of growing interest for the past two decades. Advances in cancer care have led to better patient survival, with some cancers considered as chronic or even cured diseases. The return of patients to their "pre-cancer life" can thus become an objective. Indeed, RTW after cancer is associated with improved quality of life for patients in several studies (improved financial status, improved social contacts, return of functional abilities and improved self-esteem). However, many difficulties can interfere with RTW. Many factors have been identified: disease, treatment, patient and occupational factors. The feeling of "return-to-work self-efficacy" is one of the main psychological determinants and its interest has been recently demonstrated in oncology. It corresponds to a cognitive mechanism based on expectations and/or beliefs of an individual about being able to carry out the actions required to achieve a goal, in this case RTW. The majority of studies on RTW concerns solid cancer and are retrospective. Very few studies have focused on hematological malignancies, whose prognosis was, until recently, worse. Moreover, very few interventional studies exist. There is therefore a significant need for prospective studies with appropriate methodological tools to reliably assess the benefit of interventional measures on RTW. The investigators propose to conduct a prospective, comparative, randomized, multicenter study evaluating the impact of an early RTW-consultation in patients who have been treated for a hematological malignancy. The investigators hypothesize that this consultation will improve patients' RTW rates and RTW quality. conditions: Leukemia conditions: Lymphoma conditions: Multiple Myeloma studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: SUPPORTIVE_CARE masking: NONE count: 264 type: ESTIMATED name: "Return-to-work after cancer" consultation measure: Return-to-work rate at 1 year (percentage) measure: Cumulative incidence of return-to-work at 1 year measure: Change or not of the professional situation in the 2 arms measure: Factors influencing return to work measure: Quality of life (SF-12 score) evolution measure: Anxiety and depression (HAD scale) evolution measure: Return-to-work self-efficacy (RTW-SE-11 scale) evolution measure: Self-assessment of the benefit of the "return-to-work after cancer" consultation sex: ALL minimumAge: 18 Years maximumAge: 55 Years stdAges: ADULT facility: Angers University hospital city: Angers country: France name: PAILLASSA Jérome, MD role: CONTACT phone: 02.41.35.45.24 phoneExt: +33 email: jerome.paillassa@chu-angers.fr lat: 47.46667 lon: -0.55 facility: Brest University Hospital, Morvan Site city: Brest country: France name: Marie-Anne Couturier, MD role: CONTACT phone: 02.98.22.30.37 email: marie-anne.couturier@chu-brest.fr lat: 48.3903 lon: -4.48628 facility: Caen University hospital city: Caen country: France name: Ghandi Laurent DAMAJ, MD role: CONTACT phone: 02.31.27.21.40 phoneExt: +33 email: damaj-gl@chu-caen.fr lat: 49.18585 lon: -0.35912 facility: Rennes University Hospital, Pontchaillou site city: Rennes country: France name: Roch HOUOT, MD role: CONTACT phone: 02.99.28.42.91 phoneExt: +33 email: roch.houot@chu-rennes.fr lat: 48.11198 lon: -1.67429 facility: Centre Henri Becquerel city: Rouen country: France name: Stéphane LEPRETRE, MD role: CONTACT phone: 02.32.08.22.23 phoneExt: +33 email: stephane.lepretre@chb.unicancer.fr lat: 49.44313 lon: 1.09932 facility: Rouen University Hospital city: Rouen country: France name: Laetitia ROLLIN, MD role: CONTACT phone: 02.32.88.82.69 email: laetitia.rollin@chu-rouen.fr lat: 49.44313 lon: 1.09932 facility: Tours University Hospital, Bretonneau Site city: Tours country: France name: Emmanuel GYAN role: CONTACT phone: 02.47.47.38.11 email: e.gyan@chu-tours.fr lat: 47.38333 lon: 0.68333 hasResults: False